Reported about 16 hours ago
TransMedics Group, Inc. (TMDX) has emerged as one of the top-performing healthcare stocks, with a year-to-date performance of 78.83%. The company specializes in medical technologies for organ preservation and transplantation. Following favorable analyst updates, including a price target increase to $105, TMDX is seen as a revolutionary player in its field. An executive order from President Trump aimed at reducing drug prices further strengthens the healthcare sector, providing a promising backdrop for TMDX's growth.
Source: YAHOO